Immune Response, Protein and Recombinant DNA Technology

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Immune Response

Protein

Recombinant DNA Technology

Sanofi/GSK restart COVID-19 vaccine trials after tweaking formulation

pharmaphorum

FEBRUARY 22, 2021

In December interim phase 1/2 trial results showed the vaccine produced a lower immune response in older adults. At the time analysts said that this was likely due to an insufficient concentration of the antigen and the companies have refined their antigen formulation hoping for a better immune response including in older adults.

Vaccine

Vaccine Vaccination Recombinant DNA Technology Trials

Beyond the Pill: The Rise of Biologics and the Evolution of Pharmaceutical Therapies

Cloudbyz

MARCH 6, 2024

Understanding Biologics: Biologics are a class of therapeutic agents derived from living organisms, such as cells, tissues, or proteins. Unlike traditional small molecule drugs, which are chemically synthesized, biologics are produced through complex biotechnological processes, often involving recombinant DNA technology.

Gene

Gene Immune Response Manufacturing Gene Therapy

Clinical Research Informer

Sanofi/GSK restart COVID-19 vaccine trials after tweaking formulation

Beyond the Pill: The Rise of Biologics and the Evolution of Pharmaceutical Therapies

Stay Connected